The Danish National Center for Cancer Immune Therapy (CCIT-DK) bridges the gap between discovery and clinical implementation in the field of cancer immunotherapy at Copenhagen University Hospital, Herlev and Gentofte, Department of Oncology. Strong collaboration with the Danish Cancer Society #dkforsk #dksund
SoMe manager @Lise Riber Lucassen and @Marco Donia
Company Details
- Employees
- 66
- Founded
- -
- Address
- Borgmester Ib Juuls Vej 13, Herlev,capital Region Of Denmark 2730,denmark
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Cancer Immunotherapy, Oncology, T cells, Cancer, Clinical Trials, Immunology, Healthcare, T cell therapy.
- HQ
- Herlev, Capital Region of Denmark
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark Questions
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark's website is https://www.herlevhospital.dk/ccit-denmark/Sider/default.aspx
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark's LinkedIn profile is https://dk.linkedin.com/company/ccit-dk
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark has
66 employees.
View email and phone details for 66
employees at Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark.
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark's industry is
Research Services
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark's top competitors are
Afdeling For Kræftbehandling, Herlev Og Gentofte Hospital,
Alstonia Bio Pvt Ltd,
Io Biotech,
Evaxion A/s,
Immudex,
Danish Cancer Institute,
Genmab,
Kræftens Bekæmpelse (Danish Cancer Society),
Adcendo,
Nordic Bioscience.
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark's categories are Research Services
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark's founding year is 2006
